Vasileios Bekiaris

11PUBLICATIONS
39CO-AUTHORS
Innate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyEpigenetics (incl. genome methylation and epigenomics)Molecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Nov 28, 2025
Dynamics of checkpoint receptors in γδ T cell subsets are associated with clinical response during anti-PD-1 immunotherapies.

Elisa Catafal-Tardos, Lola Dachicourt, Maria Virginia Baglioni

|May 30, 2024
IL-27 maintains cytotoxic Ly6C+ γδ T cells that arise from immature precursors.

Robert Wiesheu, Sarah C Edwards, Ann Hedley

|Jul 13, 2023
The cIAP ubiquitin ligases sustain type 3 γδ T cells and ILC during aging to promote barrier immunity.

John Rizk, Urs M Mörbe, Rasmus Agerholm

|Oct 08, 2021
Type I interferon supports γδ T-cell homeostasis and immunity through direct and indirect receptor signaling in mice.

Rasmus Agerholm, Darshana Kadekar, John Rizk

|Jul 05, 2021
Evolved to protect, designed to destroy: IL-17-producing γδ T cells in infection, inflammation, and cancer.

Rasmus Agerholm, Vasileios Bekiaris

Pageof 2